Krystal Biotech, Inc. (FRA:4KB)
Germany · Delayed Price · Currency is EUR 197.60
-1.95 (-0.98%)
At close: Dec 19, 2025
Krystal Biotech Market Cap
Krystal Biotech has a market cap or net worth of €5.96 billion as of December 22, 2025. Its market cap has increased by 16.29% in one year.
Market Cap
5.96B
Enterprise Value
5.23B
Revenue
318.05M
Ranking
n/a
PE Ratio
35.15
Stock Price
€197.60
Market Cap Chart
Since September 20, 2017, Krystal Biotech's market cap has increased from 85.56M to 5.96B, an increase of 6,864.52%. That is a compound annual growth rate of 67.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 5.96B | 36.92% |
| Dec 31, 2024 | 4.35B | 37.47% |
| Dec 29, 2023 | 3.17B | 65.87% |
| Dec 30, 2022 | 1.91B | 24.59% |
| Dec 31, 2021 | 1.53B | 58.47% |
| Dec 31, 2020 | 966.66M | 13.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.17B |
| Siemens Aktiengesellschaft | 183.57B |
| Allianz SE | 146.73B |
| Deutsche Telekom AG | 129.76B |
| Siemens Energy AG | 102.30B |
| Rheinmetall AG | 71.12B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 70.51B |
| Deutsche Bank Aktiengesellschaft | 62.30B |